SCHEMBL5680955

SCHEMBL5680955

Cc1cccc(-c2ccc3[nH]c(N)nc3c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.52
FABP6 P51161 1/20 0.49
ALDH1A1 P00352 4/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MASP2 O00187 1/20 0.47
NUDT1 P36639 1/20 0.47
AOC3 Q16853 1/20 0.47
RAB9A P51151 5/20 0.46
MAP4K4 O95819 1/20 0.46
MAPK14 Q16539 1/20 0.44
NPC1 O15118 4/20 0.43
HPGD P15428 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
GFER P55789 2/20 0.43
TP53 P04637 2/20 0.43
PKM P14618 1/20 0.43
HSD17B10 Q99714 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5679426 0.85 FABP6 (0.53) FABP6ALDH1A1MEN1KMT2AMASP2
SCHEMBL3827667 0.83 ALDH1A1 (0.58) XDHFABP6ALDH1A1MEN1KMT2A
SCHEMBL129665 0.81 FABP6 (0.60) FABP6ALDH1A1MEN1KMT2AMASP2
SCHEMBL117352 0.81 BACE1 (0.54) ALDH1A1MEN1KMT2AMASP2NUDT1
SCHEMBL5681861 0.81 ALDH1A1 (0.47) FABP6ALDH1A1MEN1KMT2AMASP2
SCHEMBL5679180 0.81 TAAR1 (0.50) FABP6ALDH1A1MEN1KMT2AMASP2
SCHEMBL5679580 0.81 MAP4K4 (0.49) XDHALDH1A1MEN1KMT2AMASP2
Bromide SCHEMBL2381776 0.80 BACE1 (0.53) ALDH1A1MEN1KMT2AMASP2NUDT1
SCHEMBL11911271 0.78 NPC1 (0.59) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL119520 0.78 XDH (0.56) XDHALDH1A1MEN1KMT2AMASP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1341769-B1 BACTERIAL GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2007-10-17 EP disclosed
EP-1620413-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2006-02-01 EP disclosed
WO-2004098494-A2 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2004-11-18 WO disclosed